how does retatrutide work for weight loss What is treatment: Boost your metabolism & Retatrutide UK 2026: Phase 3

Patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD) with concurrent diabetes or obesity might benefit from the hepatic anti-inflammatory effects observed in clinical studies, though GLP-1 receptor agonists are not yet FDA-approved specifically for liver disease

Over time, it slows down the speed at which food leaves your stomach, causing you to feel full sooner and longer

Long-Term Use for Chronic Weight Management For chronic weight management, GLP-1 therapy is often recommended as a long-term or even indefinite treatment

Retatrutide has not received marketing authorisation from the MHRA or EMA and is not available through NHS prescribing pathways

People who used Ozempic had an average weight loss of about 17%

A burgeoning community of runners, cyclists and other sports and exercise enthusiasts are taking diabetes and weight-loss drugs in the hopes of gaining a performance edge